The consequences of COVID-19 pandemic on patients with monoclonal gammopathy-associated systemic capillary leak syndrome (Clarkson disease)
- PMID: 34890829
- PMCID: PMC8648572
- DOI: 10.1016/j.jaip.2021.11.023
The consequences of COVID-19 pandemic on patients with monoclonal gammopathy-associated systemic capillary leak syndrome (Clarkson disease)
References
-
- Pineton de Chambrun M., Luyt C.-E., Beloncle F., Gousseff M., Mauhin W., Argaud L., et al. The clinical picture of severe systemic capillary-leak syndrome episodes requiring ICU admission. Crit Care Med. 2017;45:1216–1223. - PubMed
-
- Pineton de Chambrun M., Mathian A., Luyt C.-E., Combes A., Amoura Z., EurêClark Study Group Myocardial dysfunction is frequent in systemic capillary-leak syndrome (Clarkson disease) severe episodes. J Allergy Clin Immunol. 2018;141:1539–1540. - PubMed
-
- Pineton de Chambrun M., Gousseff M., Mauhin W., Lega J.-C., Lambert M., Rivière S., et al. Intravenous immunoglobulins improve survival in monoclonal gammopathy-associated systemic capillary-leak syndrome. Am J Med. 2017;130 1219.e19-27. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical